These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38287371)

  • 1. EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL.
    Pan M; Luo M; Liu L; Chen Y; Cheng Z; Wang K; Huang L; Tang N; Qiu J; Huang A; Xia J
    J Exp Clin Cancer Res; 2024 Jan; 43(1):35. PubMed ID: 38287371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
    Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional loop between YTH domain family protein YTHDF3 mediated m
    Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
    J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
    Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
    Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zheng J; Luo J; Zeng H; Guo L; Shao G
    Biomed Pharmacother; 2019 Nov; 119():109402. PubMed ID: 31514072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentinan induces apoptosis of mouse hepatocellular carcinoma cells through the EGR1/PTEN/AKT signaling axis.
    You J; Wu Q; Li Y; Li X; Lin Z; Huang J; Xue Y; Gulimiran A; Pan Y
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37264970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.
    Zhang Z; Tan X; Luo J; Yao H; Si Z; Tong JS
    Cell Death Dis; 2020 Oct; 11(10):902. PubMed ID: 33097691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
    Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.
    Zhang Q; Song G; Yao L; Liu Y; Liu M; Li S; Tang H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):14. PubMed ID: 29378599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
    Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway.
    Xiang QF; Zhan MX; Li Y; Liang H; Hu C; Huang YM; Xiao J; He X; Xin YJ; Chen MS; Lu LG
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):83-89. PubMed ID: 30663411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
    Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
    Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1/2-EGR1/DDIT3 signaling cascade.
    Xiao F; Li H; Feng Z; Huang L; Kong L; Li M; Wang D; Liu F; Zhu Z; Wei Y; Zhang W
    Sci Rep; 2021 Jan; 11(1):488. PubMed ID: 33436794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
    Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
    J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma.
    Zhang F; Wang B; Zhang W; Xu Y; Zhang C; Xue X
    Curr Cancer Drug Targets; 2024; 24(12):1235-1249. PubMed ID: 38347781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
    Yu Q; Dai W; Ji J; Wu L; Feng J; Li J; Zheng Y; Li Y; Cheng Z; Zhang J; Wu J; Xu X; Guo C
    J Cell Mol Med; 2022 May; 26(10):3031-3045. PubMed ID: 35429101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP2 suppresses the proliferation, invasion, and aerobic glycolysis of hepatocellular carcinoma cells by regulating the KDM5A/FBP1 axis.
    Yan L; Sun H; Chen Y; Yu X; Zhang J; Li P
    Environ Toxicol; 2024 Jan; 39(1):341-356. PubMed ID: 37713600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.